Successful Treatment of Relapsed Epstein–Barr Virus-Associated Hemophagocytic Lymphohistiocytosis After Allo-HSCT with PD-1 Blockade: A Case Report

BACKGROUND: Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) is a rare and aggressive disease with high mortality and poor prognosis. To date, allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only way to cure EBV-HLH. However, relapse of EBV-HLH af...

Descripción completa

Detalles Bibliográficos
Autores principales: Pi, Yubo, Wang, Jingshi, Wang, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289273/
https://www.ncbi.nlm.nih.gov/pubmed/35859915
http://dx.doi.org/10.2147/IDR.S372998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289273/
https://www.ncbi.nlm.nih.gov/pubmed/35859915
http://dx.doi.org/10.2147/IDR.S372998

Ejemplares similares